HealthWell Foundation — Urticaria Fund

Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.

Maximum award Up to $4,000 · Income ≤500% FPL · Covers drug cost only — administration billed separately

CLOSED
Status verified June 11, 2026 · Source: HealthWell Foundation fund page ↗
Fund is currently closed. Monitor for reopening.

Fund facts

Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.

Assistance type
Copay Grant
Maximum award
Up to $4,000
What it covers
Covers drug cost only — administration billed separately
Income limit
≤500% FPL
Insurance
commercial medicare medicaid tricare
Diagnosis required
Urticaria (confirmed diagnosis)
Residency
US resident
ICD-10
L50.0 L50.1 L50.2 L50.8 L50.9
Processing time
5–10 business days
Renewal
annual reapplication
Fund availability depends on donations. May close and reopen periodically.

Covered drugs in our billing library

Drugs whose J-codes this fund matches. Each links to its billing & coding reference.

Also matches J-codes not yet in our drug library: J1200

Published formulary

The foundation's own covered-medication list for this fund (81 drugs). Confirm coverage of your exact NDC at application.

Show all 81 covered medications
  • Adrenaclick
  • Adrenalin
  • Allegra
  • Auvi-q
  • Banaril
  • Brompheniramine Maleate
  • Canakinumab
  • Carbinoxamine Maleate
  • Cetirizine Hydrochloride
  • Cimetidine
  • Clarinex
  • Clemastine fumarate
  • Cyclosporine
  • Cyproheptadine Hydrochloride
  • Dapsone
  • Decadron
  • Depo-medrol
  • Desloratadine
  • Desoximetasone
  • Dex24
  • Dexabliss
  • Dexamethasone
  • Dexchlorpheniramine maleate
  • Diphenhydramine Hydrochloride
  • Doubledex
  • Doxepin
  • Doxepin Hydrochloride
  • Dupixent
  • Dxevo
  • Epinephrine
  • Epinephrine Professional Ems
  • Epinephrinesnap-v
  • Epipen Auto-injector
  • Famotidine
  • Fexofenadine Hydrochloride
  • Hemady
  • Hidex
  • Hydrocortisone Sodium Succinate
  • Hydroxyzine
  • Ilaris
  • J-tan Pd
  • Karbinal Er
  • Levocetirizine Dihydrochloride
  • Medrol
  • Methylprednisolone
  • Millipred
  • Montelukast Sodium
  • Neffy
  • Omalizumab
  • Orapred Odt
  • Pred Forte
  • Pred Mild
  • Prednisolone
  • Prednisone
  • Primatene Mist (inhalatin)
  • Quzyttir
  • Rayos
  • Remibrutinib
  • Respa-br
  • Rhapsido
  • Ryclora
  • Ryvent
  • Sandimmune
  • Sertraline Hydrochloride
  • Silenor
  • Simplist Dexamethasone
  • Singulair
  • Solu-cortef
  • Solu-medrol
  • Symjepi
  • Tagamet
  • Taperdex
  • Topicort
  • Veripred 20
  • Vistaril
  • Xolair
  • Xyzal
  • Zafirlukast
  • Zcort
  • Zoloft
  • Zyrtec

This fund is closed — here's the move

Fund status changes with donations, often without an announcement — confirm directly with the foundation at 800-675-8416, and check the alternatives below.

Manufacturer copay programs may also apply — see the drug pages: Ilaris, Xolair.

Other funds covering these drugs

Status shown as of each fund's last verification.

Common questions

Is the HealthWell Foundation Urticaria fund open?

As of June 11, 2026, the HealthWell Foundation Urticaria fund is CLOSED to new applications. Fund status changes with donations — call the foundation to confirm before turning a patient away. Verify at time of service: 800-675-8416.

How much assistance does the Urticaria fund provide?

Up to $4,000. Covers drug cost only — administration billed separately

What are the income limits for the Urticaria fund?

Household income must be ≤500% FPL. US resident.

What insurance does the Urticaria fund accept?

Accepted: commercial, medicare, medicaid, tricare.

How long does the Urticaria fund take to process an application?

The foundation's published processing time is 5–10 business days. Renewal: annual reapplication.

Patient or caregiver? Show this page to your infusion center's financial counselor — they can check what you'd qualify for and apply on your behalf, or call HealthWell Foundation at 800-675-8416.